Improving detection methods for PIK3CA mutations in breast cancer using peripheral blood from patients with metastastic breast cancer (MBC).

Authors

null

M. J. Higgins

Massachusetts General Hospital, Boston, MA

M. J. Higgins , D. Jelovac , E. Barnathan , B. Blair , S. Slater , P. Powers , J. Zorzi , S. C. Jeter , G. R. Oliver , F. Diehl , P. Angenendt , P. Huang , P. Argani , K. Murphy , A. C. Wolff , B. H. Park

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

Molecular Diagnostics and Staging

Citation

J Clin Oncol 29: 2011 (suppl; abstr 10512)

Abstract #

10512

Poster Bd #

4

Abstract Disclosures

Similar Posters

Poster

2020 ASCO Virtual Scientific Program

Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid biopsy.

Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid biopsy.

First Author: Jing Shan Lim

First Author: Priyanka Sharma

First Author: Sarah-Jane Dawson